Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Denis

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Life Sciences : CMLS|February 24, 2001
Insights from von Willebrand disease animal modelsC V Denis, D D Wagner
Journal of Thrombosis and Haemostasis : JTH|July 4, 2017
von Willebrand factor and inflammationC Kawecki, P J Lenting, C V Denis
European Journal of Cell Biology|February 11, 2000
Carboxypeptidase E does not mediate von Willebrand factor targeting to storage granulesN Methia, C V Denis, D D Wagner
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Mouse models of von Willebrand diseaseR Pendu, O D Christophe, C V Denis
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient miceC V Denis, P André, S Saffaripour, et al.
Hamostaseologie|January 20, 2009
Mouse models to study von Willebrand factor structure-function relationships in vivoC V Denis, I Marx, I Badirou, et al.
Journal of Thrombosis and Haemostasis : JTH|October 2, 2012
von Willebrand factor: the old, the new and the unknownP J Lenting, C Casari, O D Christophe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Factor VIII and von Willebrand factor--too sweet for their own goodP J Lenting, J N Pegon, O D Christophe, et al.
Blood|August 25, 2001
Localized reduction of atherosclerosis in von Willebrand factor-deficient miceN Methia, P André, C V Denis, et al.
Platelets|November 26, 2016
Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhageO Espitia, C Ternisien, C Agard, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Life Sciences : CMLS|February 24, 2001
Insights from von Willebrand disease animal modelsC V Denis, D D Wagner
Journal of Thrombosis and Haemostasis : JTH|July 4, 2017
von Willebrand factor and inflammationC Kawecki, P J Lenting, C V Denis
European Journal of Cell Biology|February 11, 2000
Carboxypeptidase E does not mediate von Willebrand factor targeting to storage granulesN Methia, C V Denis, D D Wagner
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Mouse models of von Willebrand diseaseR Pendu, O D Christophe, C V Denis
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient miceC V Denis, P André, S Saffaripour, et al.
Hamostaseologie|January 20, 2009
Mouse models to study von Willebrand factor structure-function relationships in vivoC V Denis, I Marx, I Badirou, et al.
Journal of Thrombosis and Haemostasis : JTH|October 2, 2012
von Willebrand factor: the old, the new and the unknownP J Lenting, C Casari, O D Christophe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
Factor VIII and von Willebrand factor--too sweet for their own goodP J Lenting, J N Pegon, O D Christophe, et al.
Blood|August 25, 2001
Localized reduction of atherosclerosis in von Willebrand factor-deficient miceN Methia, P André, C V Denis, et al.
Platelets|November 26, 2016
Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhageO Espitia, C Ternisien, C Agard, et al.
Pageof 3